These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32553482)

  • 1. Developing oncolytic viruses for clinical use: A consortium approach.
    Kemp V; Lamfers MLM; van der Pluijm G; van den Hoogen BG; Hoeben RC
    Cytokine Growth Factor Rev; 2020 Dec; 56():133-140. PubMed ID: 32553482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of oncolytic viruses for cancer therapy.
    Abd-Aziz N; Poh CL
    Transl Res; 2021 Nov; 237():98-123. PubMed ID: 33905949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
    Zhang Y; Liu Z
    Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic Immunotherapy.
    Hennessy ML; Bommareddy PK; Boland G; Kaufman HL
    Surg Oncol Clin N Am; 2019 Jul; 28(3):419-430. PubMed ID: 31079797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing Oncolytic Viruses for the Treatment of Cervical Cancer.
    Kalafati E; Drakopoulou E; Anagnou NP; Pappa KI
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
    Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
    Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of oncolytic virotherapy: from genetic modification to combination therapy.
    Lan Q; Xia S; Wang Q; Xu W; Huang H; Jiang S; Lu L
    Front Med; 2020 Apr; 14(2):160-184. PubMed ID: 32146606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic viruses for cancer immunotherapy.
    Hemminki O; Dos Santos JM; Hemminki A
    J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live viruses to treat cancer.
    Donnelly O; Harrington K; Melcher A; Pandha H
    J R Soc Med; 2013 Aug; 106(8):310-4. PubMed ID: 23824333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for thoracic oncology gone viral.
    Patel MR
    Immunotherapy; 2018 Apr; 10(5):383-390. PubMed ID: 29473469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering and combining oncolytic measles virus for cancer therapy.
    Leber MF; Neault S; Jirovec E; Barkley R; Said A; Bell JC; Ungerechts G
    Cytokine Growth Factor Rev; 2020 Dec; 56():39-48. PubMed ID: 32718830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future prospects for oncolytic therapy.
    McCormick F
    Oncogene; 2005 Nov; 24(52):7817-9. PubMed ID: 16299540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pros and cons of interferons for oncolytic virotherapy.
    Geoffroy K; Bourgeois-Daigneault MC
    Cytokine Growth Factor Rev; 2020 Dec; 56():49-58. PubMed ID: 32694051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2018; 18(2):202-208. PubMed ID: 28228083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in targeting cancer stem cells using oncolytic viruses.
    Zhang YN; Wang SB; Song SS; Hu PY; Zhou YC; Mou YP; Mou XZ
    Biotechnol Lett; 2020 Jun; 42(6):865-874. PubMed ID: 32166558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus, Oncolytic Virus and Human Prostate Cancer.
    Liu GB; Zhao L; Zhang L; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory aspects of oncolytic virus products.
    Yamaguchi T; Uchida E
    Curr Cancer Drug Targets; 2007 Mar; 7(2):203-8. PubMed ID: 17346112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation in Oncolytic Measles Virotherapy.
    Dietz L; Engeland CE
    Methods Mol Biol; 2020; 2058():111-126. PubMed ID: 31486034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
    Hadryś A; Sochanik A; McFadden G; Jazowiecka-Rakus J
    Eur J Pharmacol; 2020 May; 874():172991. PubMed ID: 32044323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.